BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for ADVIA Centaur CP AFP assay, Siemens

Product group In-vitro diagnostics
Reference 01600/08

Corrective action of Siemens Healthcare Diagnostics Inc. for ADVIA Centaur CP AFP and Myoglobin Assay as well as the use of the assay as an aid in the management of non-seminomatous testicular cancer because of sample dispense errors which can lead to incorrect results. The customers were informed about the problem and how to avoid it temporarily.

Corrective action for ADVIA Centaur CP AFP assay, Siemens , Download_VeroeffentlichtAm_EN PDF, 95KB, File does not meet accessibility standards